Palisade Bio, Inc.
PALI
Price:
$3.59
Market Cap:
$4.25M
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.[Read more]
Industry
Biotechnology
IPO Date
2007-03-30
Stock Exchange
NASDAQ
Ticker
PALI
The PE Ratio as of September 2024 (TTM) for Palisade Bio, Inc. (PALI) is 0.02
According to Palisade Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.02. This represents a change of -105.59% compared to the average of -0.36 of the last 4 quarters.
Palisade Bio, Inc. (PALI) Historical PE Ratio (quarterly & annually)
How has PALI PE Ratio performed in the past?
The mean historical PE Ratio of Palisade Bio, Inc. over the last ten years is -180.90. The current 0.02 PE Ratio has changed -101.11% with respect to the historical average. Over the past ten years (40 quarters), PALI's PE Ratio was at its highest in in the December 2021 quarter at 4.10. The PE Ratio was at its lowest in in the September 2017 quarter at -3121.46.
Average
-180.90
Median
-62.51
Minimum
-942.37
Maximum
-0.33
Palisade Bio, Inc. (PALI) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Palisade Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.42%
Maximum Annual PE Ratio = -0.33
Minimum Annual Increase = -98.20%
Minimum Annual PE Ratio = -942.37
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -0.33 | -8.36% |
| 2022 | -0.36 | -4.32% |
| 2021 | -0.37 | -98.20% |
| 2020 | -20.79 | 3.42% |
| 2019 | -20.10 | -80.72% |
| 2018 | -104.23 | -27.70% |
| 2017 | -144.15 | -14.78% |
| 2016 | -169.15 | -58.46% |
| 2015 | -407.17 | -56.79% |
| 2014 | -942.37 | -1.30% |
Palisade Bio, Inc. (PALI) Average PE Ratio
How has PALI PE Ratio performed in the past?
The current PE Ratio of Palisade Bio, Inc. (PALI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.35
5-year avg
-8.39
10-year avg
-180.90
Palisade Bio, Inc. (PALI) PE Ratio vs. Peers
How is PALI’s PE Ratio compared to its peers?
Palisade Bio, Inc.’s PE Ratio is greater than Zura Bio Limited (-9.00), greater than Altamira Therapeutics Ltd. (-0.03), greater than Immix Biopharma, Inc. (-2.98), greater than Enveric Biosciences, Inc. (-0.36), greater than eFFECTOR Therapeutics, Inc. (-0.00), greater than Virios Therapeutics, Inc. (-0.87), less than Navidea Biopharmaceuticals, Inc. (0.03), greater than ZyVersa Therapeutics, Inc. (-0.10), greater than Phio Pharmaceuticals Corp. (-0.15), greater than NovaBay Pharmaceuticals, Inc. (-0.05), greater than Unicycive Therapeutics, Inc. (-0.46), greater than Apexigen, Inc. (-0.36),
| Company | PE Ratio | Market cap |
|---|---|---|
| -9.00 | $230.86M | |
| -0.03 | $2.04M | |
| -2.98 | $54.08M | |
| -0.36 | $4.53M | |
| -0.00 | $188.18K | |
| -0.87 | $4.94M | |
| 0.03 | $100.08K | |
| -0.10 | $2.70M | |
| -0.15 | $2.25M | |
| -0.05 | $2.18M | |
| -0.46 | $33.41M | |
| -0.36 | $9.57M |
Build a custom stock screener for Palisade Bio, Inc. (PALI) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Palisade Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Palisade Bio, Inc. (PALI) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Palisade Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Palisade Bio, Inc.'s PE Ratio?
How is the PE Ratio calculated for Palisade Bio, Inc. (PALI)?
What is the highest PE Ratio for Palisade Bio, Inc. (PALI)?
What is the 3-year average PE Ratio for Palisade Bio, Inc. (PALI)?
What is the 5-year average PE Ratio for Palisade Bio, Inc. (PALI)?
How does the current PE Ratio for Palisade Bio, Inc. (PALI) compare to its historical average?